Back
BioXcel Therapeutics Vs. Braze Industry Stock Comparison
Sell
17
BTAI
BioXcel Therapeutics
Last Price:
2.12
Seasonality Move:
-0.19%
Sell
45
BRZE
Braze
Last Price:
40.87
Seasonality Move:
37.02%
Sell
17
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $2.37. The Score for BTAI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Braze (BRZE)
is a Sell
Is Braze a Buy, Sell or Hold?
- The current Braze [BRZE] share price is $42.05. The Score for BRZE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BRZE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $2.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
BRZE Stock Price Chart
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 36.35 | Sell |
| Chaikin Money Flow: | -631355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 2.78) | Sell |
| Bollinger Bands (100): | (2.56 - 3.26) | Sell |
BRZE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 45.87 | Sell |
| Chaikin Money Flow: | -169916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.2 - 42.82) | Buy |
| Bollinger Bands (100): | (44.52 - 56.78) | Sell |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.54 | Sell |
| 20-day SMA: | 2.65 | Sell |
| 50-day SMA: | 2.79 | Sell |
| 200-day SMA: | 3.6 | Sell |
| 8-day EMA: | 2.53 | Sell |
| 20-day EMA: | 2.62 | Sell |
| 50-day EMA: | 2.77 | Sell |
| 200-day EMA: | 5.38 | Sell |
BRZE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.88 | Buy |
| 20-day SMA: | 41.18 | Buy |
| 50-day SMA: | 46.76 | Sell |
| 200-day SMA: | 48.48 | Sell |
| 8-day EMA: | 41.76 | Buy |
| 20-day EMA: | 42.22 | Sell |
| 50-day EMA: | 45.51 | Sell |
| 200-day EMA: | 46.99 | Sell |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.16 per share.
Braze Earnings Growth & BRZE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.03 per share, an increase this year of $0.42 per share, and an increase next year of $0.18 per share.
BioXcel Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Braze Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||